Dr Reddys Laboratories (RDY) Non-Current Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Non-Current Assets for 10 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.

• Quarterly Non-Current Assets rose 3.94% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 billion (up 20.23% YoY) and the FY2026 annual result came in at $3.0 billion, up 3.94% from the prior year.
• Non-Current Assets advanced to $3.0 billion in Q1 2026 per RDY's latest filing, from $2.8 billion in the prior quarter.
• Over the last five years, Non-Current Assets for RDY reached as high as $3.0 billion in Q1 2026 and fell as low as $1.4 billion in Q1 2023.
• A 5-year average of $2.1 billion and a median of $1.7 billion in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets fell 8.73% — and 2025, when it jumped 69.89%.
• Year by year, Non-Current Assets stood at $1.5 billion in 2022, then retreated by 4.44% to $1.4 billion in 2023, then increased by 19.74% to $1.7 billion in 2024, then soared by 69.89% to $2.8 billion in 2025, then gained by 3.94% to $3.0 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.0 billion, $2.8 billion, and $1.7 billion for Q1 2026, Q1 2025, and Q1 2024 respectively.